Table 1.
Clinical features at time of diagnosis
| Case No. | Age(yr) | IAHSS | New onset AIH | BMI(m/kg2) | HE | SIRS | Bilirubin(mg/dL) | ALT(IU/L) | ALP(UI/L) | INR | Globulin(g/dL) | Creatinine(mg/dL) | ANA | Corticosteroids |
| 1.31 | 65 | 17 | Yes | 31.1 | 2 | Yes | 21.9 | 309 | 274 | 1.60 | 4.1 | 1.1 | 1:40 | Yes |
| 1.22 | 17 | 17 | Yes | 22.0 | 3 | Yes | 15.3 | 358 | 136 | 1.50 | 2.5 | 0.9 | 1:40 | Yes |
| 23 | 66 | 17 | No | 20.0 | 2 | Yes | 8.4 | 31 | 207 | 1.50 | 4.4 | 0.9 | 1:80 | Yes |
| 1.24 | 28 | 17 | Yes | 30.3 | 2 | Yes | 22.9 | 128 | 262 | 1.90 | 5.7 | 1.1 | 1:80 | Yes |
| 1.25 | 52 | 14 | Yes | 27.5 | 2 | No | 21.2 | 217 | 186 | 1.90 | 4.5 | 0.6 | 1:40 | No |
| 16 | 17 | 20 | Yes | 22.5 | 2 | No | 7.6 | 414 | 271 | 1.70 | 7.7 | 0.8 | 1:80 | Yes |
| 7 | 31 | 18 | No | 19.9 | 4 | Yes | 22.0 | 541 | 138 | 3.60 | 2.9 | 6.6 | 1:80 | Yes |
| 8 | 25 | 14 | No | 35.0 | 3 | Yes | 26.8 | 23 | 309 | 1.90 | 3.1 | 2.7 | 1:40 | No |
| 1.39 | 67 | 13 | Yes | 26.9 | 2 | No | 13.8 | 683 | 135 | 8.12 | 2.4 | 2.3 | 1:80 | No |
| 10 | 18 | 12 | Yes | 27.0 | 3 | Yes | 22.6 | 126 | 120 | 2.20 | 2.7 | 1.1 | 1:40 | No |
| 11 | 33 | 13 | Yes | 23.3 | 3 | Yes | 20.1 | 173 | 199 | 3.60 | 4.3 | 1.4 | 1:80 | No |
IAHSS: international autoimmune hepatitis scoring system; HE: hepatic encephalopathy grade; SIRS: systemic inflammatory response syndrome; ALT: alanine aminotransferase; ALP: alkaline phosphatase; INR: international normalized ratio; ANA: antinuclear antibody; BMI: body mass index.
1
Cases treated with corticosteroids,
2
Cases that survived one month, 3Cases that survived more than three years.